Y Combinator is launching a biotech track

 Y Combinator is pulling the curtains off of a new experiment, YC Bio. The idea is to fund early-stage life-sciences companies that are still in the lab phase, YC President Sam Altman wrote on the YC blog today. YC Bio’s first area of focus will be on healthspan and age-related disease. Read More

Read more
January 11, 2018 at 12:32PM

from TechCrunch
via IFTTT